ENYO Pharma Employee Directory
Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees
ENYO Pharma is a clinical-stage biotechnology research company based in Lyon, France, focused on developing therapeutics with fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. Its lead compound, Vonafexor, is in Phase 2 trials for chronic kidney disease and Alport syndrome. The company employs 11-50 people and is located at 9-13 Rue Des Cuirassiers, Lyon, Auvergne-rhône-alpes 69003 France. ENYO Pharma has completed Series C financing with Vesalius Biocapital IV and progressed the ALPESTRIA-1 Phase 2 study in Alport syndrome, with reported revenue in the range of $1M-$10M. In 2026, Jeff George was appointed Non-Executive Chairman of the Board to support the next phase of growth and Phase 3 readiness.